neopharma.io

What It Is

NeoPharma is an AI-driven pharmaceutical lead discovery platform built for pharma sales teams. Its core goal is to help sales reps identify the right physician targets faster and understand their prescribing behavior, research activity, affiliations, and contact information before outreach. The page states that 500+ pharmaceutical sales professionals are already on the waitlist, with coverage of 180,000+ verified physician profiles, 25 million+ prescription analyses, and 400,000+ tracked research activities.

Core Capabilities

The product’s key capabilities center on “physician intelligence + AI search.” Users can filter by specialty, location, prescribing patterns, research activity, and other criteria, or use NEO AI to ask questions in natural language—for example, finding cardiologists in a specific city who are prescribing a competing drug. The platform then generates actionable target lists and displays prescription history, research activity, affiliations, and contact information. It also supports exporting lists and syncing them to a CRM, making it easier to move from research into sales follow-up.

Pricing and Trial

The current page only offers Request Early Access and Schedule a Demo. It does not publicly disclose pricing, plans, seat counts, a free trial, or any free usage allowance. Before purchasing, buyers will need to confirm data coverage, cost structure, CRM integration scope, and contract terms through a demo.

Pros and Cons

Its main strength is its highly vertical focus. The product is designed around the real workflow of pharmaceutical sales teams, making it especially suitable for teams that need to prioritize targets based on actual prescribing behavior. Natural-language querying lowers the barrier to searching complex databases, while claims around continuous updates and multi-source verification may also help improve the credibility of sales intelligence.

The downside is that public information remains limited. The page does not explain the underlying AI models, detailed data sources, covered countries or regions, refresh frequency, compliance basis for prescription data, specific CRM names, API capabilities, or security certifications. For a highly regulated sector such as healthcare data, enterprise buyers will still need to conduct further due diligence on privacy, compliance, and data traceability.

Who It’s For and Access from China

NeoPharma is better suited to pharmaceutical sales teams, business development teams, and sales operations professionals promoting drugs to physicians in Western markets. China access cannot be determined from the available text, and payment methods are not disclosed. If using it from China, buyers should specifically confirm whether it can be accessed directly, whether it covers Chinese physicians and prescription data, whether Chinese-language queries are supported, and whether it meets local healthcare data compliance requirements.